Avaliação de novos compostos antimicrobianos na inibição da formação do biofilme de Escherichia coli

• Ano de defesa: 2014
• Autor(a) principal: Mizdal, Caren Rigon
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal de Santa Maria; BR; Análises Clínicas e Toxicológicas; UFSM; Programa de Pós-Graduação em Ciências Farmacêuticas
• Palavras-chave em Português: Biofilme; Antibacterianos; Sulfametoxazol; Escherichia coli; Biofilm; Antibacterial; Sulfamethoxazole; CNPQ::CIENCIAS DA SAUDE::FARMACIA
• Link de acesso: http://repositorio.ufsm.br/handle/1/5997

The bacterial deposition on surface and also the biofilm form occurring widely in the nature as a protection strategy developed for the bacteria against the harmful external factors. Microorganism, when was in biofilm form was able to generate several problems for the public heath justly for showed a higher resistance from the action of antibacterial agents when compared with the planktonic form. Bacteria are the microorganism more involved with the biofilm production in the presence of beneficial environmental conditions. In this way, Escherichia coli were the strain more involved with the process of adhesion in the surfaces. Few studies were developed to found new antimicrobial drugs precisely because the researches presented more interest to improve the known drugs. Thus, the present study was evaluated the antibiofilm capability of sulfamethoxazole (SMTZ) alone and when complexed with metals as mercury, copper, cadmium and silver. The compounds were tested against Escherichia coli (ATCC 25922). For evaluated the inhibition of the biofilm formation we were used microplates of polystyrene to observe the turbidity through the 570 nm in an ELISA plate reader. The results presented that the sulfamethoxazole compounds had an excellent antibiofilm activity and also that the complex SMTZ-Ag showed the best inhibitory activity against E. coli biofilm formation. Therefore, we conclude that these sulfamethoxazole complexed compounds require more researches in order to expand their antimicrobial activity.